Global survey of healthcare practitioners' beliefs and practices around intrauterine contraceptive method use in nulliparous women

Contraception

Volumn 88, Issue 5, 2013, Pages 650-656

  Black, Kirsten I ^a   Lotke, Pamela ^b   Lira, Josefina ^c   Peers, Tina ^d   Zite, Nikki B ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d Sexual Health Services Surrey for Virgincare   (United Kingdom)

^e UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Healthcare practitioners; Intrauterine contraception; Intrauterine device; Knowledge; Nulliparous

Indexed keywords

ARGENTINA; ARTICLE; ATTITUDE TO HEALTH; AUSTRALIA; BRAZIL; CANADA; COLOMBIA; CONTRACEPTIVE BEHAVIOR; CONTROLLED STUDY; EUROPE; FEMALE; GERMANY; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH CARE SURVEY; HEALTH SERVICE; HUMAN; INFERTILITY; INTRAUTERINE CONTRACEPTIVE DEVICE; IRELAND; MEXICO; NETHERLANDS; NULLIPARA; PELVIC INFLAMMATORY DISEASE; RUSSIAN FEDERATION; SOUTH AND CENTRAL AMERICA; SWEDEN; TURKEY (REPUBLIC); UNITED STATES; WORLD HEALTH ORGANIZATION;

HEALTHCARE PRACTITIONERS; INTRAUTERINE CONTRACEPTION; INTRAUTERINE DEVICE; KNOWLEDGE; NULLIPAROUS;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; FAMILY PLANNING SERVICES; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFERTILITY, FEMALE; INTERNET; INTRAUTERINE DEVICES; MALE; MIDWIFERY; NURSES; PARITY; PELVIC INFLAMMATORY DISEASE; PHYSICIANS; PRACTICE GUIDELINES AS TOPIC; RISK; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84885331924     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.06.005     Document Type: Article

References (26)

1. National Research Council Initial national priorities for comparative effectiveness research 2009 National Academies Press Washington, DC
2. National Collaborating Centre for Women's and Children's Health Commissioned by the National Institute for Health and Clinical Excellence. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception 2005 RCOG Press London
3. B. Winner, J.F. Peipert, Q. Zhao, C. Buckel, T. Madden, and J.E. Allsworth Effectiveness of long-acting reversible contraception N Eng J Med 366 21 2012 1998 2007
4. I. Mavranezouli, and L.G.D. Group The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline Hum Reprod 23 6 2008 1338 1345 (Pubitemid 351770574)
5. A. Berrington Perpetual postponers? Women's, men's and couple's fertility intentions and subsequent fertility behaviour Popul Trends 117 2004 9 19
6. World Health Organization Medical eligibility criteria for contraceptive use 4th edition 2010. Accessed 28/02/2012 Available from: http://www.who.int/ reproductive-health/publications/mec.pdf
7. D.T. Baird, J. Collins, J. Egozcue, L.H. Evers, L. Gianaroli, and H. Leridon Fertility and ageing Hum Reprod Update 11 3 2005 261 276 (Pubitemid 40668111)
8. American College of Obstetricians and Gynecologists ACOG Committee opinion no. 392, December 2007. Intrauterine device and adolescents Obstet Gynecol 110 6 2007 1493 1495
9. American College of Obstetricians and Gynecologists Committee on Gynecologic P, Long-Acting Reversible Contraception Working G ACOG Committee opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy Obstet Gynecol 114 6 2009 1434 1438
10. S. Haimovich Profile of long-acting reversible contraception users in Europe Eur J Contracept Reprod Health Care 14 3 2009 187 195
11. D. Cibula Women's contraceptive practices and sexual behaviour in Europe Eur J Contracept Reprod Health Care 13 4 2008 362 375
12. United Nations World contraceptive use 2011 http://www.un.org/esa/ population/publications/contraceptive2011/contraceptive2011.htm 2011 Last accessed May 5th, 2013.
13. K. Black, T. Sakhaei, and S. Garland A study investigating obstetricians and gynaecologist management of women requesting an intrauterine device Aust N Z J Obstet Gynaecol 50 2 2010 184 188
14. N. Stanwood, J. Garrett, and T. Konrad Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice Obstet Gynecol 99 2002 275 280 (Pubitemid 34114001)
15. A. Middleton, J. Naish, and N. Singer General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK Eur J Contracept Reprod Health Care 16 2011 311 318
16. K. Wellings, Z. Zhihong, A. Krentel, G. Barrett, and A. Glasier Attitudes towards long-acting reversible methods of contraception in general practice in the UK Contraception 76 3 2007 208 214 (Pubitemid 47247663)
17. D. Grimes Intrauterine device and upper-genital-tract infection Lancet 356 9234 2000 1013 1019
18. T.M. Farley, M.J. Rosenberg, P.J. Rowe, J.H. Chen, and O. Meirik Intrauterine devices and pelvic inflammatory disease: an international perspective Lancet 339 8796 1992 785 788
19. D. Hubacher, R. Lara-Ricalde, D.J. Taylor, F. Guerra-Infante, and R. Guzman-Rodriguez Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women N Eng J Med 345 8 2001 561 567 (Pubitemid 32772097)
20. R. Lyus, P. Lohr, and S. Prager Board of the Society of Family Planning. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women Contraception 81 5 2010 367 371
21. L. Marions, L. Lovkvist, A. Taube, M. Johansson, H. Dalvik, and I. Overlie Use of the levonorgestrel releasing-intrauterine system in nulliparous women - a non-interventional study in Sweden Eur J Contracept Reprod Health Care 16 2 2011 126 134
22. M. Bahamondes, M. Hidalgo, L. Bahamondes, and I. Monteiro Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas Contraception 84 2011 e11 e16
23. C. Harvey, D. Bateson, J. Wattimena, and K.I. Black Ease of intrauterine contraceptive device insertion in family planning settings Aust N Z J Obstet Gynaecol 52 6 2012 534 539
24. K. Maguire, A. Davis, L.R. Tejeda, and C. Westhoff Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial Contraception 86 3 2012 214 219
25. K. Dijkhuizen, O.M. Dekkers, and C.A. Holleboom Vaginal misoprostol prior to insertion of an intrauterine device: an RCT Hum Reprod 26 2011 323 329
26. D. Hubacher, V. Reyes, S. Lillo, A. Zepeda, P.-L. Chen, and H. Croxatto Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen Am J Obstet Gynecol 195 5 2006 1272 1277 (Pubitemid 44635393)